NUMD - Nu-Med Plus, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0000 (0.00%)
At close: 3:30PM EST
Stock chart is not supported by your current browser
Previous Close0.7500
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.7500 - 0.7500
52 Week Range0.3000 - 1.0100
Avg. Volume332
Market Cap30.701M
Beta (3Y Monthly)1.30
PE Ratio (TTM)N/A
EPS (TTM)-0.03
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire2 months ago

    Nu-Med Plus, Inc. President Helps Lead Call for New Innovation in Inhaled Nitric Oxide Industry

    In it he writes about the untapped potential of inhaled nitric oxide. When delivered in precise doses, inhaled nitric oxide has already been proven to stabilize blood pressure, open airways, fight infections and blood clots, treat erectile dysfunction and combat aging. Robins writes about what he sees as a stagnated inhaled nitric oxide industry which he believes has not delivered on the full potential of the life-saving molecule, and “the true potential of nitric oxide has, I believe, been bottled up by one or two major corporations.

  • GlobeNewswire2 months ago

    Nu-Med Plus, Inc. Advances Blood and Plasma Transfusion Technology with New Patent

    Nitric oxide is naturally occurring in blood and acts as a vasodilator by expanding and dilating blood vessels. According to recent studies1, the longer blood is stored, the more nitric oxide is depleted, increasing potential risks to patients such as hypoxia, infection, and heart failure.

  • We're sorry this is all we were able to find about this topic.